Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-03-23

FDA Approved: ZIANA — Supplemental Application (Bausch Health US, LLC)

View source ↗

Summary

FDA approved a supplemental application for ZIANA, a topical combination of clindamycin phosphate and tretinoin, submitted by Bausch Health US, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ZIANA (CLINDAMYCIN PHOSPHATE AND TRETINOIN)

Snippet

SUPPL AP for ZIANA (CLINDAMYCIN PHOSPHATE AND TRETINOIN)